Keyphrases
Parkinson's Disease
100%
Continuous Infusion
100%
Levodopa-carbidopa Intestinal Gel
100%
Levodopa
80%
Motor Complications
60%
Dyskinesia
40%
Double Dummy
40%
Adverse Effects
20%
Disability
20%
Parkinson Patients
20%
Pulsatile
20%
Placebo Groups
20%
Advanced Parkinson's Disease
20%
Lancet
20%
Odin
20%
Levodopa Therapy
20%
Motor Fluctuations
20%
Medicine and Dentistry
Parkinson's Disease
100%
Continuous Infusion
100%
Carbidopa/Levodopa
100%
Levodopa
100%
Infusion
40%
Dyskinesia
40%
Adverse Event
20%
Placebo
20%
Valerian
20%
Intrajejunal Drug Administration
20%
Neuroscience
Parkinson's Disease
100%
L-DOPA
100%
Carbidopa/Levodopa
100%
Dyskinesia
40%
Dopaminergic
20%
Adverse Effect
20%
Placebo
20%
Valerian
20%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Levodopa
100%
Carbidopa Plus Levodopa
100%
Dyskinesia
40%
Adverse Event
20%
Dopamine Receptor Stimulating Agent
20%
Placebo
20%
Valerian
20%